LONDON, June 24, 2022 /PRNewswire/ Minimally Invasive Surgical Instruments Market is valued at USD 20.18 Billion in 2021 and expected to reach USD 32.19 Billion by 2028 with a CAGR
/PRNewswire/ As per a study by Transparency Market Research (TMR), the global urology devices market is estimated to register growth at a CAGR of 5.6%.
Surge in the prevalence of kidney-related health issues globally is bolstering the global urology devices marketPresence of favorable reimbursement policies and technological advancements in
Instruments by Geographic Region - USA, Canada, Japan, China,
Europe, Asia-Pacific and Rest of World Markets - Independent
Analysis of Annual Sales in US$ Million for Years 2020 through
2027 and % CAGR
by Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific and Rest of World Markets - Independent Analysis
of Annual Sales in US$ Million for Years 2012 through 2019 and
% CAGR
Instruments by Geographic Region - Percentage Breakdown of
Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific
and Rest of World Markets for Years 2012, 2020 & 2027
Table 4: World Current & Future Analysis for Consumables &
Accessories by Geographic Region - USA, Canada, Japan, China,
Europe, Asia-Pacific and Rest of World Markets - Independent
Benign Prostatic Hyperplasia Treatment Market worth $14.1 billion by 2026 - Exclusive Report by MarketsandMarkets Benign Prostatic Hyperplasia Treatment Market by Type [Drug (Alpha Blockers(Tamsulosin, Doxazosin), 5-Alpha Reductase Inhibitors (Finasteride, Dutasteride), Surgical Treatment (TURP, TUMT, TUNA], End User (Hospitals) - Global Forecast to 2026 , published by MarketsandMarkets, the Global BPH Treatment Market is projected to reach USD 14.1 billion by 2026 from USD 10.8 billion in 2021, at a CAGR of 5.3% from 2021 to 2026.
Browse in-depth TOC on
130 - Tables
Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=198000374
The growth of this BPH Treatment Market is driven by the increasing prevalence of benign prostatic hyperplasia, the rising preference for minimally invasive surgeries, increasing obesity rate, and investments, funds, and grants for research in the field of BPH treatment.